|
1
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Scheel C and Weinberg RA: Cancer stem
cells and epithelial-mesenchymal transition: Concepts and molecular
links. Semin Cancer Biol. 22:396–403. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tiwari N, Gheldof A, Tatari M and
Christofori G: EMT as the ultimate survival mechanism of cancer
cells. Semin Cancer Biol. 22:194–207. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
de Herreros AG, Peiró S, Nassour M and
Savagner P: Snail family regulation and epithelial mesenchymal
transitions in breast cancer progression. J Mammary Gland Biol
Neoplasia. 15:135–147. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu Y and Zhou BP: Snail: More than EMT.
Cell Adhes Migr. 4:199–203. 2010. View Article : Google Scholar
|
|
7
|
Moody SE, Perez D, Pan TC, Sarkisian CJ,
Portocarrero CP, Sterner CJ, Notorfrancesco KL, Cardiff RD and
Chodosh LA: The transcriptional repressor Snail promotes mammary
tumor recurrence. Cancer Cell. 8:197–209. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Foroni C, Broggini M, Generali D and Damia
G: Epithelial-mesenchymal transition and breast cancer: Role,
molecular mechanisms and clinical impact. Cancer Treat Rev.
38:689–697. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Theys J, Jutten B, Habets R, Paesmans K,
Groot AJ, Lambin P, Wouters BG, Lammering G and Vooijs M:
E-cadherin loss associated with EMT promotes radioresistance in
human tumor cells. Radiother Oncol. 99:392–397. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song H, Kim TO, Ma SY, Park JH, Choi JH,
Kim JH, Kang MS, Bae SK, Kim KH, Kim TH, et al: Intratumoral
heterogeneity impacts the response to anti-neu antibody therapy.
BMC Cancer. 14:6472014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma SY, Song H, Park JH, Choi JH, Kim JH,
Kim KH, Park S, Park DH, Kang MS, Kwak M, et al: Addition of
anti-neu antibody to local irradiation can improve tumor-bearing
BALB/c mouse survival through immune-mediated mechanisms. Radiat
Res. 183:271–278. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lim SO, Gu JM, Kim MS, Kim HS, Park YN,
Park CK, Cho JW, Park YM and Jung G: Epigenetic changes induced by
reactive oxygen species in hepatocellular carcinoma: Methylation of
the E-cadherin promoter. Gastroenterology. 135:2128–2140,
2140.e1-8. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nieto MA: The snail superfamily of
zinc-finger transcription factors. Nat Rev Mol Cell Biol.
3:155–166. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dong C, Wu Y, Yao J, Wang Y, Yu Y,
Rychahou PG, Evers BM and Zhou BP: G9a interacts with Snail and is
critical for Snail-mediated E-cadherin repression in human breast
cancer. J Clin Invest. 122:1469–1486. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Harney AS, Meade TJ and LaBonne C:
Targeted inactivation of Snail family EMT regulatory factors by a
Co(III)-Ebox conjugate. PLoS One. 7:e323182012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou W, Lv R, Qi W, Wu D, Xu Y, Liu W, Mou
Y and Wang L: Snail contributes to the maintenance of stem
cell-like phenotype cells in human pancreatic cancer. PLoS One.
9:e874092014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Olmeda D, Moreno-Bueno G, Flores JM, Fabra
A, Portillo F and Cano A: SNAI1 is required for tumor growth and
lymph node metastasis of human breast carcinoma MDA-MB-231 cells.
Cancer Res. 67:11721–11731. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Olmeda D, Montes A, Moreno-Bueno G, Flores
JM, Portillo F and Cano A: Snai1 and Snai2 collaborate on tumor
growth and metastasis properties of mouse skin carcinoma cell
lines. Oncogene. 27:4690–4701. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang A, Chen G, Meng L, Wang Q, Hu W, Xi
L, Gao Q, Wang S, Zhou J, Xu G, et al: Antisense-Snail transfer
inhibits tumor metastasis by inducing E-cadherin expression.
Anticancer Res. 28A:621–628. 2008.
|
|
20
|
Smith BN, Burton LJ, Henderson V, Randle
DD, Morton DJ, Smith BA, Taliaferro-Smith L, Nagappan P, Yates C,
Zayzafoon M, et al: Snail promotes epithelial mesenchymal
transition in breast cancer cells in part via activation of nuclear
ERK2. PLoS One. 9:e1049872014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee K and Nelson CM: New insights into the
regulation of epithelial-mesenchymal transition and tissue
fibrosis. Int Rev Cell Mol Biol. 294:171–221. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Blanco MJ, Moreno-Bueno G, Sarrio D,
Locascio A, Cano A, Palacios J and Nieto MA: Correlation of Snail
expression with histological grade and lymph node status in breast
carcinomas. Oncogene. 21:3241–3246. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mezencev R, Matyunina LV, Jabbari N and
McDonald JF: Snail-induced epithelial-to-mesenchymal transition of
MCF-7 breast cancer cells: Systems analysis of molecular changes
and their effect on radiation and drug sensitivity. BMC Cancer.
16:2362016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Abraham BK, Fritz P, McClellan M,
Hauptvogel P, Athelogou M and Brauch H: Prevalence of
CD44+/CD24−/low cells in breast cancer may
not be associated with clinical outcome but may favor distant
metastasis. Clin Cancer Res. 11:1154–1159. 2005.PubMed/NCBI
|
|
25
|
Ponti D, Costa A, Zaffaroni N, Pratesi G,
Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ginestier C, Hur MH, Charafe-Jauffret E,
Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG,
Liu S, et al: ALDH1 is a marker of normal and malignant human
mammary stem cells and a predictor of poor clinical outcome. Cell
Stem Cell. 1:555–567. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jaggupilli A and Elkord E: Significance of
CD44 and CD24 as cancer stem cell markers: An enduring ambiguity.
Clin Dev Immunol. 2012:7080362012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
de Beça FF, Caetano P, Gerhard R,
Alvarenga CA, Gomes M, Paredes J and Schmitt F: Cancer stem cells
markers CD44, CD24 and ALDH1 in breast cancer special histological
types. J Clin Pathol. 66:187–191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Santisteban M, Reiman JM, Asiedu MK,
Behrens MD, Nassar A, Kalli KR, Haluska P, Ingle JN, Hartmann LC,
Manjili MH, et al: Immune-induced epithelial to mesenchymal
transition in vivo generates breast cancer stem cells. Cancer Res.
69:2887–2895. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pajonk F, Vlashi E and McBride WH:
Radiation resistance of cancer stem cells: The 4 R's of
radiobiology revisited. Stem Cells. 28:639–648. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yin H and Glass J: The phenotypic
radiation resistance of CD44+/CD24(−or low)
breast cancer cells is mediated through the enhanced activation of
ATM signaling. PLoS One. 6:e240802011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang P, Wei Y, Wang L, Debeb BG, Yuan Y,
Zhang J, Yuan J, Wang M, Chen D, Sun Y, et al: ATM-mediated
stabilization of ZEB1 promotes DNA damage response and
radioresistance through CHK1. Nat Cell Biol. 16:864–875. 2014.
View Article : Google Scholar : PubMed/NCBI
|
